Transitions, Risks, and Actions in Coronary Events--Center for Outcomes Research and Education (TRACE-CORE): design

Molly E Waring1, Richard H McManus, Jane S Saczynski

  • 1Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA 01655, USA. molly.waring@umassmed.edu

Insights

The Transitions, Risks, and Actions in Coronary Events Center for Outcomes Research and Education (TRACE-CORE) study examines acute coronary syndromes. It aims to improve patient transitions from hospital to community, reducing mortality and enhancing quality of life.

Area of Science:

  • Cardiovascular disease outcomes research
  • Health services research
  • Clinical epidemiology

Background:

  • Cardiovascular disease significantly impacts morbidity, mortality, and quality of life.
  • Underuse of evidence-based practices limits health gains.
  • The TRACE-CORE initiative addresses acute coronary syndromes (ACS).

Purpose of the Study:

  • To examine determinants and outcomes of hospital-to-community transition quality in ACS patients.
  • To quantify the impact of modifiable factors on quality of life, rehospitalization, and mortality.
  • To develop and validate predictive action scores for recurrent cardiac events and mortality.

Main Methods:

  • Longitudinal, multiracial cohort study of 2500 ACS patients across 6 US hospitals.
  • 24-month follow-up including medical record abstraction and patient interviews.
  • Development of action scores to predict outcomes and a patient/provider dashboard.

Main Results:

  • Currently enrolling patients for a comprehensive longitudinal study.
  • Focus on modifiable factors influencing patient transitions and outcomes.
  • Anticipates development of predictive scores for cardiac events and mortality.

Conclusions:

  • TRACE-CORE integrates observational study principles with outcomes and effectiveness research.
  • Expected to inform novel secondary prevention strategies for cardiovascular disease.
  • Aims to foster the careers of cardiovascular outcomes researchers.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...